Storys zum Thema Genetik
-
Sprache:
Englisch
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- mehr
Maria-Elena Torres-Padilla Honored With the Leibniz Prize 2025
mehrTechnische Universität München
Complex pancreatic tumor organoids as foundation for new treatment strategies
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE Foundation for new cancer treatment strategies Organoids represent the complex cell landscape of pancreatic cancer - Tumors are composed of cancer cells with a variety of different characteristics. - This contributes significantly to the complexity of pancreatic cancer and makes the disease difficult to treat. - For the ...
mehrInceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapies
mehrTechnische Universität München
New method for designing artificial proteins
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE Designing large new proteins with AI New method for designing artificial proteins - Efficient design of new proteins with desired properties - Size of newly designed proteins is approaching that of antibodies - Predicted protein structures successfully validated in experiments Protein design aims to create customized antibodies for therapies, biosensors for diagnostics, or ...
mehrRHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU
mehr
Technische Universität München
What gave the first molecules their stability?
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE New insights into the origins of life What gave the first molecules their stability? • Until now, it was unclear how complex molecules could survive in the primordial soup• Unstable RNA molecules are stabilized by double strands • RNAs may be able to form their own complementary strand The origins of life remain a major mystery. How were complex molecules able to form and ...
mehrNew Study: Father's Diet Before Conception Influences Children's Health
mehrPress Release: Restless Legs Syndrome: Genetic Discoveries Advance Treatment and Risk Prediction
Researchers at Helmholtz Munich and the Technical University of Munich (TUM) together with international collaborators have conducted the largest genetic investigation of the restless legs syndrome to date. Their findings, ...
mehrPress release: Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK
Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK - Bio-Thera and STADA have reached an exclusive commercialization and license agreement for BAT2506, a biosimilar candidate to Simponi® ...
Ein DokumentmehrTechnische Universität München
Boron deficiency: oilseed rape reacts as with infection and pest infestation | Genetic mechanisms uncovered
TECHNICAL UNIVERSITY OF MUNICH PRESS RELEASE Genetic mechanisms uncovered Boron deficiency: oilseed rape reacts as with infection and pest infestation - Oilseed rape reacts to boron deficiency during flowering in a similar way as to pests and infections - Boron deficiency could become an increasing problem due to ...
mehrResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘
mehr
Fraunhofer-Institut für Produktionstechnologie IPT
Pooling expertise: Fraunhofer IPT and Harro Höfliger cooperate in the manufacturing of ATMP production systems
mehrTechnische Universität München
Start-up dedicated to developing new antibiotics
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE Smartbax nominated for Falling Walls award Start-up dedicated to developing new antibiotics • New approach against resistant pathogens • Agent damages protein transport and energy balance of bacteria • Two TUM spin-offs nominated for Science Breakthrough of the Year at Falling Walls Summit It all began with basic research: While conducting laboratory experiments, a team ...
mehrRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affected
mehrBjörn Cochlovius New CEO of Eleva / Seasoned Molecular Biologist and Entrepreneur Leads German Biotech Company into its Next Development
Freiburg, Germany (ots) - Björn Cochlovius Ph.D. has become the new CEO of Eleva, a Freiburg-based biotech company and the developer of “Bryotechnology”, a unique and pioneering process for the moss-based production of complex therapeutic proteins. The renowned oncologist, immunologist, and molecular biologist ...
mehrTechnische Universität München
Genetically encoded nano-barcodes
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE Electron microscopy: Nano-reporter proteins make invisible processes visible Genetically encoded nano-barcodes - New gene reporter system for electron microscopy - Uses barcodes to identify cellular states and structures that would otherwise remain unidentified - Important step to better elucidate cellular structural changes also in disease How do the nerve cells in our brain communicate with each other? What processes take place ...
mehrSwiss Start-Up “Mirai Foods” produces first cultivated tender steak / Breakthrough for Cultivated Premium Beef Steaks
Zurich (ots) - - Three patents for key technologies in “cultivated meat” - Food producer Angst AG takes stake in company - Innovative bioreactor improves efficiency and reduces costs A real new meat experience without sacrifice: Swiss start-up Mirai Foods achieves technological breakthrough for the cultivation ...
mehr
VectorBuilder vann första pris i stor innovationstävling
Chicago, IL (ots) - --News Direct-- VectorBuilder Inc. - en global ledare inom genleveransteknik - meddelade att deras FoU- och tillverkningscenter i Guangzhou vann mästerskapet i sjunde globala tävlingen i innovation och företagande, som hölls i "Chuangke" Hangzhou, Kina. Denna inflytelserika och mycket konkurrensdrivna tävling är en av de största i Kina och täcker företag i tillväxtstadiet inom alla ...
mehrTechnische Universität München
Why are overweight people more susceptible to illness?
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22778 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/news-and-events/all-news/press-releases/details/warum-bekommen-uebergewichtige-menschen-haeufiger-erkrankungen Picture: https://mediatum.ub.tum.de/1612044 NEWS RELEASE Why are overweight people more susceptible to illness? Size of fat cells can cause ...
mehrVectorBuilder Won First Prize in Major Innovation Competition
Chicago, IL (ots) - --News Direct-- VectorBuilder Inc. – a global leader in gene delivery technologies – announced that its R&D and manufacturing center in Guangzhou won championship in the 7th “Chuangke Innovation and Entrepreneurship Global Competition” held in Hangzhou, China. This influential and highly competitive contest is one of the largest in China, covering growth-stage enterprises across all high-tech ...
mehrTechnische Universität München
Nanoswitches for tumor targeting
TECHNICAL UNIVERSITY OF MUNICHCorporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de Video: https://www.youtube.com/watch?v=_xXV0mCke1g NEWS RELEASE Nanoswitches for tumor targeting TUM spin-off Plectonic develops antibody-based immunotherapies Plectonic Biotech, a spin-off of the Technical University of Munich (TUM), has developed a nanoswitch that binds immune cells to tumor cells. The goal is to facilitate the development of ...
mehrFlu tests from R-Biopharm also detect new virus variants
mehrTechnische Universität München
Molecular monitoring of RNA regulation
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10808 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/news-and-events/all-news/press-releases/details/molecular-monitoring-of-rna-regulation Pictures: https://mediatum.ub.tum.de/1691366 NEWS RELEASE Molecular monitoring of RNA regulation New biological tool for tracking cellular processes The better we ...
mehr
Stem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa research
mehrTechnische Universität München
Alzheimer's disease and type 2 diabetes: Synthetic peptides may suppress formation of harmful amyloid aggregates
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22779 - email: presse@tum.de - web: www.tum.de Image download: https://mediatum.ub.tum.de/652209?show_id=1691364 NEWS RELEASE Alzheimer's disease and type 2 diabetes: Synthetic peptides may suppress formation of harmful amyloid ...
mehrVectorBuilder Raised $57 Million for Gene Delivery R&D
mehrVectorBuilder raised $57 million for gene delivery R&D
mehrbenfovir AG has reached another milestone by completing the first part of the Phase 1 trial testing transketolase inhibitor / benfo-oxythiamine (B-OT)
Darmstadt (ots) - benfovir AG, a German pharmaceutical company focused on developing small molecules against viral infections such as SARS-CoV-2, dengue and herpes virus, today announced that the first part of the Phase 1 clinical trial (BV-01-101/ EudraCT Number: 2021-005616-60.) designed to evaluate the safety, ...
mehrTechnische Universität München
More wheat for global food security: Utilizing substantial genetic potential for higher yields
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/37551 High resolution image: https://mediatum.ub.tum.de/1655486 NEWS RELEASE More wheat for global food ...
mehr